RE: From Inan23 Aug 2022 19:14
Berm,
"4) If it's true, why have shareholders found out from a stock bulletin board that their CEO has moved from a part time to full time role and is no longer Professor of Immunotherapy at the University of Nottingham?"
....because this is Scancell .....